Culture Watch Update
SEE OTHER BRANDS

Your top news on culture, society and lifestyle

Culture Watch Update: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Culture Watch Update.

Press releases published on April 2, 2025

Opus Genetics to Participate in Upcoming Investor Conference in April

Opus Genetics to Participate in Upcoming Investor Conference in April

RESEARCH TRIANGLE PARK, N.C., April 02, 2025 (GLOBE NEWSWIRE) -- Opus Genetics, Inc. (Nasdaq: IRD), a clinical-stage ophthalmic biotechnology company developing gene therapies for the treatment of inherited retinal diseases (IRDs) and therapies for other …

VAN RYSEL EXPANDS U.S. DISTRIBUTION CHANNELS FOR ROAD AND GRAVEL OFFERINGS

VAN RYSEL EXPANDS U.S. DISTRIBUTION CHANNELS FOR ROAD AND GRAVEL OFFERINGS

San Francisco, CA, April 02, 2025 (GLOBE NEWSWIRE) -- VAN RYSEL, the expert French cycling brand owned by DECATHLON announces its newly expanded U.S. distribution channels including more retail distributors as well as direct-to-consumer and click-and- …

Ovid Therapeutics to Present at the 24th Annual Needham Virtual Healthcare Conference

Ovid Therapeutics to Present at the 24th Annual Needham Virtual Healthcare Conference

NEW YORK, April 02, 2025 (GLOBE NEWSWIRE) -- Ovid Therapeutics Inc. (NASDAQ: OVID), a biopharmaceutical company dedicated to developing medicines for brain conditions with significant unmet need, today announced that Meg Alexander, President and Chief …

UniFirst Announces Financial Results for the Second Quarter of Fiscal 2025

UniFirst Announces Financial Results for the Second Quarter of Fiscal 2025

WILMINGTON, Mass., April 02, 2025 (GLOBE NEWSWIRE) -- UniFirst Corporation (NYSE: UNF) (the “Company,” “UniFirst” or “we”) today reported results for its second quarter ended March 1, 2025 as compared to the corresponding period in the prior fiscal year: …

Infinidat Earns 5-Star Rating in the 2025 CRN® Partner Program Guide for the Fourth Consecutive Year

Infinidat Earns 5-Star Rating in the 2025 CRN® Partner Program Guide for the Fourth Consecutive Year

WALTHAM, Mass., April 02, 2025 (GLOBE NEWSWIRE) -- Infinidat, a leading provider of enterprise storage solutions, today announced that the company has been recognized by CRN®, a brand of The Channel Company, with a 5-Star Award in the 2025 CRN Partner …

Gabelli Funds to Host 11th Annual Waste & Sustainability Symposium Thursday, April 3, 2025

Gabelli Funds to Host 11th Annual Waste & Sustainability Symposium Thursday, April 3, 2025

GREENWICH, Conn., April 02, 2025 (GLOBE NEWSWIRE) -- Gabelli Funds, LLC, will host the 11th Annual Waste …

Pest Busterzz Launches Comprehensive Termite Control Services in South Florida

Pest Busterzz Launches Comprehensive Termite Control Services in South Florida

Tamarac, FL, April 02, 2025 (GLOBE NEWSWIRE) -- Pest Busterzz, a proud family-owned organic pest control company dedicated to offering eco-friendly and sustainable pest control solutions, is happy to announce the launch of its comprehensive termite control …

Palvella Therapeutics Announces Late-Breaking Oral Presentation at the 15th World Congress of Pediatric Dermatology

Palvella Therapeutics Announces Late-Breaking Oral Presentation at the 15th World Congress of Pediatric Dermatology

WAYNE, Pa., April 02, 2025 (GLOBE NEWSWIRE) -- (Nasdaq: PVLA) Palvella Therapeutics, Inc. (Palvella or “the Company”), a clinical-stage biopharmaceutical company focused on developing and commercializing novel therapies to treat patients suffering from …

XOMA Royalty to Present at Jones Healthcare and Technology Innovation Conference

XOMA Royalty to Present at Jones Healthcare and Technology Innovation Conference

EMERYVILLE, Calif., April 02, 2025 (GLOBE NEWSWIRE) -- XOMA Royalty Corporation (“XOMA”; NASDAQ: XOMA), the biotech royalty aggregator, announced today Chief Investment Officer, Brad Sitko, will be a featured presenter at the Jones Healthcare and …

Sensei Biotherapeutics to Participate in the Canaccord Genuity Horizons in Oncology Virtual Conference

Sensei Biotherapeutics to Participate in the Canaccord Genuity Horizons in Oncology Virtual Conference

BOSTON, April 02, 2025 (GLOBE NEWSWIRE) -- Sensei Biotherapeutics, Inc. (Nasdaq: SNSE), a clinical stage biotechnology company focused on the discovery and development of next-generation therapeutics for cancer patients, today announced that John Celebi, …

Pyxis Oncology to Participate in the Stifel 2025 Virtual Targeted Oncology Forum

Pyxis Oncology to Participate in the Stifel 2025 Virtual Targeted Oncology Forum

BOSTON, April 02, 2025 (GLOBE NEWSWIRE) -- Pyxis Oncology, Inc. (Nasdaq: PYXS), a clinical-stage company developing next-generation therapeutics for difficult-to-treat cancers, today announced that Lara S. Sullivan, M.D., President, Chief Executive Officer …

Bathroom Vanities Market Size to Reach US$ 52.90 Billion by 2031: In-Depth Research Report by The Insight Partners

Bathroom Vanities Market Size to Reach US$ 52.90 Billion by 2031: In-Depth Research Report by The Insight Partners

US …

Vital Signs Monitoring Devices Market Set to Reach USD 66.82 Billion by 2030, Growing at a CAGR of 12.7% - Exclusive Report by The Insight Partners

Vital Signs Monitoring Devices Market Set to Reach USD 66.82 Billion by 2030, Growing at a CAGR of 12.7% - Exclusive Report by The Insight Partners

US …

Marex Group plc provides preliminary Q1 results range and hosts Investor Day in New York

Marex Group plc provides preliminary Q1 results range and hosts Investor Day in New York

NEW YORK, April 02, 2025 (GLOBE NEWSWIRE) -- Marex Group plc (Nasdaq: MRX) (‘Marex’), the diversified global financial services platform, provides a Q1 trading update at its Investor Day, being held today at the Nasdaq Marketsite in New York City. Marex …

Syntiant to Unveil Vision Transformer Security Solution at ISC West 2025

Syntiant to Unveil Vision Transformer Security Solution at ISC West 2025

IRVINE, Calif., April 02, 2025 (GLOBE NEWSWIRE) -- Syntiant Corp., the recognized leader in low-power edge AI deployment, today announced it will demonstrate its multimodal vision transformer (ViT) at ISC West 2025 in Las Vegas, April 2-4. Deployed on an …

Employee Trust Fuels Financial Success at the 100 Best Companies to Work For in 2025

Employee Trust Fuels Financial Success at the 100 Best Companies to Work For in 2025

Oakland, Calif., April 02, 2025 (GLOBE NEWSWIRE) -- Can employee trust be measured in dollars and cents? The 2025 Fortune 100 Best Companies to Work For® have proven that the answer is a resounding yes. On average, the 100 Best Companies earn 8.5 times …

Syndax Announces Participation at the Stifel 2025 Virtual Targeted Oncology Forum

Syndax Announces Participation at the Stifel 2025 Virtual Targeted Oncology Forum

NEW YORK, April 02, 2025 (GLOBE NEWSWIRE) -- Syndax Pharmaceuticals (Nasdaq: SNDX), a commercial-stage biopharmaceutical company developing an innovative pipeline of cancer therapies, today announced that Michael A. Metzger, Chief Executive Officer of …

Autolus Therapeutics to Participate in the 24th Annual Needham Virtual Healthcare Conference

Autolus Therapeutics to Participate in the 24th Annual Needham Virtual Healthcare Conference

LONDON, April 02, 2025 (GLOBE NEWSWIRE) -- Autolus Therapeutics plc (Nasdaq: AUTL), an early commercial-stage biopharmaceutical company developing, manufacturing and delivering next-generation programmed T cell therapies, announces that the Company will …

Green Thumb Industries to Hold First Quarter 2025 Earnings Conference Call on May 7, 2025

Green Thumb Industries to Hold First Quarter 2025 Earnings Conference Call on May 7, 2025

CHICAGO and VANCOUVER, British Columbia, April 02, 2025 (GLOBE NEWSWIRE) -- Green Thumb Industries Inc. (Green Thumb) (CSE: GTII) (OTCQX: GTBIF), a leading national cannabis consumer packaged goods company and owner of RISE Dispensaries, today announced it …

Acumen Pharmaceuticals Showcases pTau217 Trial Screening Progress in Phase 2 ALTITUDE-AD Trial and Preclinical Research Methods at AD/PD 2025 and AAN Annual Meeting

Acumen Pharmaceuticals Showcases pTau217 Trial Screening Progress in Phase 2 ALTITUDE-AD Trial and Preclinical Research Methods at AD/PD 2025 and AAN Annual Meeting

NEWTON, Mass., April 02, 2025 (GLOBE NEWSWIRE) -- Acumen Pharmaceuticals, Inc. (NASDAQ: ABOS), a clinical-stage biopharmaceutical company developing a novel therapeutic that targets toxic soluble amyloid beta oligomers (AβOs) for the treatment of Alzheimer …

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms of Service